The multifaceted role of SMAD4 in immune cell function

被引:0
作者
Cui, Xinmu [1 ]
Song, Yu [1 ]
Han, Jianfeng [1 ,2 ]
Yuan, Zhaoxin [1 ]
机构
[1] Changchun Med Coll, 6177 Jilin St, Changchun 130031, Peoples R China
[2] Cellular Biomed Grp Inc, Shanghai 201203, Peoples R China
关键词
SMAD4; Immune cells; Autoimmune disorders; Cancer; GROWTH-FACTOR-BETA; REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; TOLEROGENIC DENDRITIC CELLS; CLASS-SWITCH RECOMBINATION; TGF-BETA; CANCER-IMMUNOTHERAPY; TISSUE-REPAIR; POLARIZATION; ACTIVATION;
D O I
10.1016/j.bbrep.2024.101902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Transforming Growth Factor-beta (TGF-(3) signaling pathway, with SMAD4 as its central mediator, plays a pivotal role in regulating cellular functions, including growth, differentiation, apoptosis, and immune responses. While extensive research has elucidated SMAD4's role in tumorigenesis, its functions within immune cells remain underexplored. This review synthesizes current knowledge on SMAD4's diverse roles in various immune cells such as T cells, B cells, dendritic cells, and macrophages, highlighting its impact on immune homeostasis and pathogen response. Understanding SMAD4's role in immune cells is crucial, as its dysregulation can lead to autoimmune disorders, chronic inflammation, and immune deficiencies. The review emphasizes the significance of SMAD4 in immune regulation, proposing that deeper investigation could reveal novel therapeutic targets for immune-mediated conditions. Insights into SMAD4's involvement in processes like T cell differentiation, B cell class switch recombination, and macrophage polarization underscore its potential as a therapeutic target for a range of diseases, including autoimmune disorders and cancer.
引用
收藏
页数:9
相关论文
共 116 条
[1]   Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer [J].
Aitchison, Alan A. ;
Veerakumarasivam, Abhi ;
Vias, Maria ;
Kumar, Rajeev ;
Hamdy, Freddie C. ;
Neal, David E. ;
Milis, Ian G. .
PROSTATE, 2008, 68 (06) :661-674
[2]   Human peripheral blood mononuclear cells as a valuable source of disease-related biomarkers: Evidence from comparative proteomics studies [J].
Alexovic, Michal ;
Ulicna, Csilla ;
Sabo, Jan ;
Davalieva, Katarina .
PROTEOMICS CLINICAL APPLICATIONS, 2024, 18 (02)
[3]   Human peripheral blood mononuclear cells: A review of recent proteomic applications [J].
Alexovic, Michal ;
Lindner, Joshua Raoul ;
Bober, Peter ;
Longuespee, Remi ;
Sabo, Jan ;
Davalieva, Katarina .
PROTEOMICS, 2022, 22 (15-16)
[4]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Germinal centres and B cell lymphomagenesis [J].
Basso, Katia ;
Dalla-Favera, Riccardo .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (03) :172-184
[7]   Transforming Growth Factor-β Signaling in Immunity and Cancer [J].
Batlle, Eduard ;
Massague, Joan .
IMMUNITY, 2019, 50 (04) :924-940
[8]   A decade of exploring the cancer epigenome - biological and translational implications [J].
Baylin, Stephen B. ;
Jones, Peter A. .
NATURE REVIEWS CANCER, 2011, 11 (10) :726-734
[9]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[10]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550